Compartilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Hematology, Transfusion and Cell Therapy
Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects’ eligibility?
Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Layane Marques de Souza, Maria do Rosario Ferraz Roberti
10.1016/j.htct.2021.07.008
Hematol Transfus Cell Ther. 2022;44:1-6
Open access
SARS-COV-2: is it a risk for blood transfusion?
Dante Mário Langhi, Renato Cerqueira de Souza, Melca Barros, Gil Cunha De Santis, Simone Haddad Kashima, Jose Orlando Bordin
10.1016/j.htct.2021.08.001
Hematol Transfus Cell Ther. 2022;44:100-3
Open access
Effect of ABO blood groups on length of hospital stay according to age in Covid-19 patients
Vildan Gursoy, Suna Avci
10.1016/j.htct.2021.08.013
Hematol Transfus Cell Ther. 2022;44:7-12
Open access
ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review
Sapha Shibeeb, Aisha Khan
10.1016/j.htct.2021.07.006
Hematol Transfus Cell Ther. 2022;44:70-5
Open access
THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU
10.1016/j.htct.2021.10.979
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19-20
Open access
IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
Elrazi Ali, Qusai Maharmeh, Waail Rozi, Mohamed Yassin
10.1016/j.htct.2021.10.984
Hematol Transfus Cell Ther. 2021;43 Supl 3:S22
Open access
PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
Seda Şahin, Neriman Sarı, Derya Özyörük, Sonay İncesoy Özdemir, Belgin Gülhan, İnci Ergürhan İlhan
10.1016/j.htct.2021.10.1007
Hematol Transfus Cell Ther. 2021;43 Supl 3:S31
Open access
INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Filip Callewaert, Hilde De Winter
10.1016/j.htct.2021.10.1047
Hematol Transfus Cell Ther. 2021;43 Supl 3:S46-7
Open access
IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
Hana Qasim
10.1016/j.htct.2021.10.1046
Hematol Transfus Cell Ther. 2021;43 Supl 3:S46
Open access
HEMATOLOGICAL FINDINGS IN COVID-19 AND INSIGHTS TO STEM CELL THERAPY
Ghada ELGohary
10.1016/j.htct.2021.10.1050
Hematol Transfus Cell Ther. 2021;43 Supl 3:S48
Open access
Conteúdo especial sobre COVID-19
- Prevalence of anti-HLA antibodies in COVID-19 convalescent plasma donors: an Indian experience
- 2 - Anuncio Acreditacao
- DOES PET/CT WITH 18F-FLUOROESTRADIOL (18F-FES) CONTRIBUTE TO THE ASSESSMENT OF BREAST CANCER COMPARED TO FLUORINE-2-D-DEOXYGLUCOSE (18F-FDG)?
- Anti-PF4 antibodies and their relationship with COVID infection
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.